RecruitingISRCTN11473174
Genetic testing to guide psychiatric medication for adults of Arab heritage
About this title
Clinical implementation of preemptive pharmacogenomics-guided prescription in psychiatry
Read the official source — ISRCTN11473174Research studyAges 18–65QatarDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Qatar
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Qatar Precision Health Institute (QPHI)
- Sponsor type
- Research institute
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- Qatar
- Age range
- From 18 Years to 65 Years
- Official registry ID
- ISRCTN11473174
- Official title
Show the full official title
Using genetic testing to guide psychiatric medication prescribing
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Qatar
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Qatar Precision Health Institute (QPHI), a research institute.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
Genetically guided medication choices for depression, bipolarity and psychosis
Effects of implementing a comfort room in an acute mental health unit on seclusion rates and client’s level of distress.
